Cairo – Mubasher: The board of October Pharma approved the estimated budget for 2022, expecting a net profit after tax worth EGP 135 million by the end of the year.
The company also targets sales worth EGP 775 million this year, according to a bourse disclosure on Monday.
October Pharma also expected total assets worth EGP 783.26 million as on 31 December 2021.
It is worth noting that during the first nine months (9M) of 2021, the company reported net profits of EGP 100.32 million.
